Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IC Sciences (Infection Control Sciences) is a life science company dedicated to the development and commercialization of innovative antimicrobial technologies designed to reduce healthcare-associated infections (HAIs). The company's core business revolves around its proprietary IC Pro technology, a persistent antimicrobial coating that provides long-lasting protection against a broad spectrum of pathogens on various surfaces. Their products are primarily utilized in clinical settings to enhance environmental hygiene and patient safety by preventing the transmission of infectious agents. IC Sciences offers a suite of solutions including surface treatments and specialized application systems tailored for hospitals and long-term care facilities. By bridging the gap between traditional cleaning and continuous protection, the company aims to significantly lower infection rates and associated healthcare costs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IC Sciences.